Efficacy and safety of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
Not Applicable
Completed
- Conditions
- severe chronic kidney disease complicated by congestive heart failure
- Registration Number
- JPRN-UMIN000029787
- Lead Sponsor
- Department of Nephrology, Nippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Hemodynamics are unstable 2) Hypersensitivity to tolvaptan 3) Anuria 4) Can not feel dry mouth or can not drink water 5) Hypernatremia 6) Pregnant 7) Already prescribed tolvaptan 8) Patient judged inappropriate by the examining physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change rate to eGFR <6 (mL / min / 1.73 m2)
- Secondary Outcome Measures
Name Time Method